The global market for Nuclear Pharmacy was valued at US$ 9611 million in the year 2024 and is projected to reach a revised size of US$ 17568 million by 2031, growing at a CAGR of 9.0% during the forecast period.

Nuclear Pharmacy Market

Nuclear pharmaceutical products, also known as radiopharmaceuticals, are a class of precise diagnostic or therapeutic agents formed by labeling radionuclides onto specific carrier molecules. Their core principle is to utilize the combination of radiation emitted by the radionuclide and the biological targeting properties of the drug carrier to achieve precise visualization of diseases or internal irradiation therapy. Based on their application, they can be divided into two main categories: diagnostic radiopharmaceuticals, which use single-photon emission computed tomography (SPECT) or positron emission tomography (PET) to detect tumors and cardiovascular diseases at an early stage at the cellular metabolic or molecular functional level; and therapeutic radiopharmaceuticals, which can precisely deliver radiation energy to diseased cells, achieving "targeted internal radiotherapy." The research and application of these products are highly interdisciplinary, involving nuclear physics, radiochemistry, pharmacy, and medicine. Their production, quality control, and use are subject to strict dual regulation by national drug regulatory agencies and nuclear safety departments.

The nuclear pharmaceutical industry chain is a technology-intensive, strictly regulated, and highly collaborative specialized chain. The upstream is the core and bottleneck link, involving the production and supply of medical radionuclides. It relies on nuclear reactors or cyclotron irradiation targets to produce short-half-life radionuclides, and the stability of its supply is a global challenge. The midstream involves drug preparation, labeling, and quality control. Pharmaceutical companies or medical institutions rapidly and with high purity label the nuclide with specific precursor compounds in GMP-compliant and radiation-safe "hot chambers" or automated synthesis modules, completing rigorous sterility, pyrogen-free, radiochemical purity, and activity testing. This process is often measured in minutes or hours to address nuclide decay. The downstream involves clinical distribution and application. An efficient logistics network ensures timely delivery of products to hospital nuclear medicine departments, where specialized teams use them for patient imaging diagnosis or targeted therapy. The entire industry chain is interconnected and heavily reliant on a stable supply of nuclides, advanced labeling technology, a comprehensive quality control system, and close collaboration between pharmaceutical, medical device, and medical institutions.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Nuclear Pharmacy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Pharmacy.

The Nuclear Pharmacy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nuclear Pharmacy market comprehensively. Regional market sizes, concerning products by Type, by Application, by Isotope Types and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Nuclear Pharmacy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Nuclear Pharmacy Market Report

Report Metric	Details
Report Name	Nuclear Pharmacy Market
Accounted market size in year	US$ 9611 million
Forecasted market size in 2031	US$ 17568 million
CAGR	9.0%
Base Year	year
Forecasted years	2026 - 2031
Segment by Type	Diagnostic Products Therapeutic Products
Segment by Isotope Types	Technetium-99m Fluorine-18 Gallium-68 Iodine-123 Indium-111 Copper-64 Xenon-133 Iodine-131 Yttrium-90 Lutetium-177 Strontium-89 Samarium-153 Radium-223 Iodine-125 Other
Segment by Production Method	Reactor-based Nuclide Production Accelerator-based Nuclide Production Others
Segment by Application	Pharmaceutical Hospital Laboratory
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bayer, Curium Pharma, Jubilant Pharmova, GE Healthcare, Cardinal Health, Eli Lilly, Bracco Imaging, China Isotope & Radiation, Novartis, Siemens, Lantheus Medical Imaging, Aurobindo Pharma, ANSTO, Polatom, NTP Radioisotopes, Yantai Dongcheng Pharmaceutical, Saide Biotechnology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Isotope Types etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nuclear Pharmacy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Nuclear Pharmacy Market growing?

Ans: The Nuclear Pharmacy Market witnessing a CAGR of 9.0% during the forecast period 2026-2031.

What is the Nuclear Pharmacy Market size in 2031?

Ans: The Nuclear Pharmacy Market size in 2031 will be US$ 17568 million.

Who are the main players in the Nuclear Pharmacy Market report?

Ans: The main players in the Nuclear Pharmacy Market are Bayer, Curium Pharma, Jubilant Pharmova, GE Healthcare, Cardinal Health, Eli Lilly, Bracco Imaging, China Isotope & Radiation, Novartis, Siemens, Lantheus Medical Imaging, Aurobindo Pharma, ANSTO, Polatom, NTP Radioisotopes, Yantai Dongcheng Pharmaceutical, Saide Biotechnology

What are the Application segmentation covered in the Nuclear Pharmacy Market report?

Ans: The Applications covered in the Nuclear Pharmacy Market report are Pharmaceutical, Hospital, Laboratory

What are the Type segmentation covered in the Nuclear Pharmacy Market report?

Ans: The Types covered in the Nuclear Pharmacy Market report are Technetium-99m, Fluorine-18, Gallium-68, Iodine-123, Indium-111, Copper-64, Xenon-133, Iodine-131, Yttrium-90, Lutetium-177, Strontium-89, Samarium-153, Radium-223, Iodine-125, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Nuclear Pharmacy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Diagnostic Products

1.2.3 Therapeutic Products

1.3 Market by Isotope Types

1.3.1 Global Nuclear Pharmacy Market Size Growth Rate by Isotope Types: 2020 VS 2024 VS 2031

1.3.2 Technetium-99m

1.3.3 Fluorine-18

1.3.4 Gallium-68

1.3.5 Iodine-123

1.3.6 Indium-111

1.3.7 Copper-64

1.3.8 Xenon-133

1.3.9 Iodine-131

1.3.10 Yttrium-90

1.4 Market by Production Method

1.4.1 Global Nuclear Pharmacy Market Size Growth Rate by Production Method: 2020 VS 2024 VS 2031

1.4.2 Reactor-based Nuclide Production

1.4.3 Accelerator-based Nuclide Production

1.4.4 Others

1.5 Market by Application

1.5.1 Global Nuclear Pharmacy Market Growth by Application: 2020 VS 2024 VS 2031

1.5.2 Pharmaceutical

1.5.3 Hospital

1.5.4 Laboratory

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Global Growth Trends

2.1 Global Nuclear Pharmacy Market Perspective (2020-2031)

2.2 Global Nuclear Pharmacy Growth Trends by Region

2.2.1 Global Nuclear Pharmacy Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Nuclear Pharmacy Historic Market Size by Region (2020-2025)

2.2.3 Nuclear Pharmacy Forecasted Market Size by Region (2026-2031)

2.3 Nuclear Pharmacy Market Dynamics

2.3.1 Nuclear Pharmacy Industry Trends

2.3.2 Nuclear Pharmacy Market Drivers

2.3.3 Nuclear Pharmacy Market Challenges

2.3.4 Nuclear Pharmacy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Nuclear Pharmacy Players by Revenue

3.1.1 Global Top Nuclear Pharmacy Players by Revenue (2020-2025)

3.1.2 Global Nuclear Pharmacy Revenue Market Share by Players (2020-2025)

3.2 Global Top Nuclear Pharmacy Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Nuclear Pharmacy Revenue

3.4 Global Nuclear Pharmacy Market Concentration Ratio

3.4.1 Global Nuclear Pharmacy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Nuclear Pharmacy Revenue in 2024

3.5 Global Key Players of Nuclear Pharmacy Head office and Area Served

3.6 Global Key Players of Nuclear Pharmacy, Product and Application

3.7 Global Key Players of Nuclear Pharmacy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Nuclear Pharmacy Breakdown Data by Type

4.1 Global Nuclear Pharmacy Historic Market Size by Type (2020-2025)

4.2 Global Nuclear Pharmacy Forecasted Market Size by Type (2026-2031)

5 Nuclear Pharmacy Breakdown Data by Application

5.1 Global Nuclear Pharmacy Historic Market Size by Application (2020-2025)

5.2 Global Nuclear Pharmacy Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Nuclear Pharmacy Market Size (2020-2031)

6.2 North America Nuclear Pharmacy Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Nuclear Pharmacy Market Size by Country (2020-2025)

6.4 North America Nuclear Pharmacy Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Nuclear Pharmacy Market Size (2020-2031)

7.2 Europe Nuclear Pharmacy Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Nuclear Pharmacy Market Size by Country (2020-2025)

7.4 Europe Nuclear Pharmacy Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Nuclear Pharmacy Market Size (2020-2031)

8.2 Asia-Pacific Nuclear Pharmacy Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Nuclear Pharmacy Market Size by Region (2020-2025)

8.4 Asia-Pacific Nuclear Pharmacy Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Nuclear Pharmacy Market Size (2020-2031)

9.2 Latin America Nuclear Pharmacy Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Nuclear Pharmacy Market Size by Country (2020-2025)

9.4 Latin America Nuclear Pharmacy Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Nuclear Pharmacy Market Size (2020-2031)

10.2 Middle East & Africa Nuclear Pharmacy Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Nuclear Pharmacy Market Size by Country (2020-2025)

10.4 Middle East & Africa Nuclear Pharmacy Market Size by Country (2026-2031)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Bayer

11.1.1 Bayer Company Details

11.1.2 Bayer Business Overview

11.1.3 Bayer Nuclear Pharmacy Introduction

11.1.4 Bayer Revenue in Nuclear Pharmacy Business (2020-2025)

11.1.5 Bayer Recent Development

11.2 Curium Pharma

11.2.1 Curium Pharma Company Details

11.2.2 Curium Pharma Business Overview

11.2.3 Curium Pharma Nuclear Pharmacy Introduction

11.2.4 Curium Pharma Revenue in Nuclear Pharmacy Business (2020-2025)

11.2.5 Curium Pharma Recent Development

11.3 Jubilant Pharmova

11.3.1 Jubilant Pharmova Company Details

11.3.2 Jubilant Pharmova Business Overview

11.3.3 Jubilant Pharmova Nuclear Pharmacy Introduction

11.3.4 Jubilant Pharmova Revenue in Nuclear Pharmacy Business (2020-2025)

11.3.5 Jubilant Pharmova Recent Development

11.4 GE Healthcare

11.4.1 GE Healthcare Company Details

11.4.2 GE Healthcare Business Overview

11.4.3 GE Healthcare Nuclear Pharmacy Introduction

11.4.4 GE Healthcare Revenue in Nuclear Pharmacy Business (2020-2025)

11.4.5 GE Healthcare Recent Development

11.5 Cardinal Health

11.5.1 Cardinal Health Company Details

11.5.2 Cardinal Health Business Overview

11.5.3 Cardinal Health Nuclear Pharmacy Introduction

11.5.4 Cardinal Health Revenue in Nuclear Pharmacy Business (2020-2025)

11.5.5 Cardinal Health Recent Development

11.6 Eli Lilly

11.6.1 Eli Lilly Company Details

11.6.2 Eli Lilly Business Overview

11.6.3 Eli Lilly Nuclear Pharmacy Introduction

11.6.4 Eli Lilly Revenue in Nuclear Pharmacy Business (2020-2025)

11.6.5 Eli Lilly Recent Development

11.7 Bracco Imaging

11.7.1 Bracco Imaging Company Details

11.7.2 Bracco Imaging Business Overview

11.7.3 Bracco Imaging Nuclear Pharmacy Introduction

11.7.4 Bracco Imaging Revenue in Nuclear Pharmacy Business (2020-2025)

11.7.5 Bracco Imaging Recent Development

11.8 China Isotope & Radiation

11.8.1 China Isotope & Radiation Company Details

11.8.2 China Isotope & Radiation Business Overview

11.8.3 China Isotope & Radiation Nuclear Pharmacy Introduction

11.8.4 China Isotope & Radiation Revenue in Nuclear Pharmacy Business (2020-2025)

11.8.5 China Isotope & Radiation Recent Development

11.9 Novartis

11.9.1 Novartis Company Details

11.9.2 Novartis Business Overview

11.9.3 Novartis Nuclear Pharmacy Introduction

11.9.4 Novartis Revenue in Nuclear Pharmacy Business (2020-2025)

11.9.5 Novartis Recent Development

11.10 Siemens

11.10.1 Siemens Company Details

11.10.2 Siemens Business Overview

11.10.3 Siemens Nuclear Pharmacy Introduction

11.10.4 Siemens Revenue in Nuclear Pharmacy Business (2020-2025)

11.10.5 Siemens Recent Development

11.11 Lantheus Medical Imaging

11.11.1 Lantheus Medical Imaging Company Details

11.11.2 Lantheus Medical Imaging Business Overview

11.11.3 Lantheus Medical Imaging Nuclear Pharmacy Introduction

11.11.4 Lantheus Medical Imaging Revenue in Nuclear Pharmacy Business (2020-2025)

11.11.5 Lantheus Medical Imaging Recent Development

11.12 Aurobindo Pharma

11.12.1 Aurobindo Pharma Company Details

11.12.2 Aurobindo Pharma Business Overview

11.12.3 Aurobindo Pharma Nuclear Pharmacy Introduction

11.12.4 Aurobindo Pharma Revenue in Nuclear Pharmacy Business (2020-2025)

11.12.5 Aurobindo Pharma Recent Development

11.13 ANSTO

11.13.1 ANSTO Company Details

11.13.2 ANSTO Business Overview

11.13.3 ANSTO Nuclear Pharmacy Introduction

11.13.4 ANSTO Revenue in Nuclear Pharmacy Business (2020-2025)

11.13.5 ANSTO Recent Development

11.14 Polatom

11.14.1 Polatom Company Details

11.14.2 Polatom Business Overview

11.14.3 Polatom Nuclear Pharmacy Introduction

11.14.4 Polatom Revenue in Nuclear Pharmacy Business (2020-2025)

11.14.5 Polatom Recent Development

11.15 NTP Radioisotopes

11.15.1 NTP Radioisotopes Company Details

11.15.2 NTP Radioisotopes Business Overview

11.15.3 NTP Radioisotopes Nuclear Pharmacy Introduction

11.15.4 NTP Radioisotopes Revenue in Nuclear Pharmacy Business (2020-2025)

11.15.5 NTP Radioisotopes Recent Development

11.16 Yantai Dongcheng Pharmaceutical

11.16.1 Yantai Dongcheng Pharmaceutical Company Details

11.16.2 Yantai Dongcheng Pharmaceutical Business Overview

11.16.3 Yantai Dongcheng Pharmaceutical Nuclear Pharmacy Introduction

11.16.4 Yantai Dongcheng Pharmaceutical Revenue in Nuclear Pharmacy Business (2020-2025)

11.16.5 Yantai Dongcheng Pharmaceutical Recent Development

11.17 Saide Biotechnology

11.17.1 Saide Biotechnology Company Details

11.17.2 Saide Biotechnology Business Overview

11.17.3 Saide Biotechnology Nuclear Pharmacy Introduction

11.17.4 Saide Biotechnology Revenue in Nuclear Pharmacy Business (2020-2025)

11.17.5 Saide Biotechnology Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Curium Pharma

Cardinal Health

GE Healthcare

China Isotope & Radiation

Novartis

Siemens AG

Lantheus Medical Imaging

Yantai Dongcheng Pharmaceutical

Saide Biotechnology

List of Tables

Table 1. Global Nuclear Pharmacy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Diagnostic Products

Table 3. Key Players of Therapeutic Products

Table 4. Global Nuclear Pharmacy Market Size Growth Rate by Isotope Types (US$ Million): 2020 VS 2024 VS 2031

Table 5. Key Players of Technetium-99m

Table 6. Key Players of Fluorine-18

Table 7. Key Players of Gallium-68

Table 8. Key Players of Iodine-123

Table 9. Key Players of Indium-111

Table 10. Key Players of Copper-64

Table 11. Key Players of Xenon-133

Table 12. Global Nuclear Pharmacy Market Size Growth Rate by Production Method (US$ Million): 2020 VS 2024 VS 2031

Table 13. Key Players of Reactor-based Nuclide Production

Table 14. Key Players of Accelerator-based Nuclide Production

Table 15. Key Players of Others

Table 16. Global Nuclear Pharmacy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Nuclear Pharmacy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 18. Global Nuclear Pharmacy Market Size by Region (2020-2025) & (US$ Million)

Table 19. Global Nuclear Pharmacy Market Share by Region (2020-2025)

Table 20. Global Nuclear Pharmacy Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 21. Global Nuclear Pharmacy Market Share by Region (2026-2031)

Table 22. Nuclear Pharmacy Market Trends

Table 23. Nuclear Pharmacy Market Drivers

Table 24. Nuclear Pharmacy Market Challenges

Table 25. Nuclear Pharmacy Market Restraints

Table 26. Global Nuclear Pharmacy Revenue by Players (2020-2025) & (US$ Million)

Table 27. Global Nuclear Pharmacy Market Share by Players (2020-2025)

Table 28. Global Top Nuclear Pharmacy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Pharmacy as of 2024)

Table 29. Ranking of Global Top Nuclear Pharmacy Companies by Revenue (US$ Million) in 2024

Table 30. Global 5 Largest Players Market Share by Nuclear Pharmacy Revenue (CR5 and HHI) & (2020-2025)

Table 31. Global Key Players of Nuclear Pharmacy, Headquarters and Area Served

Table 32. Global Key Players of Nuclear Pharmacy, Product and Application

Table 33. Global Key Players of Nuclear Pharmacy, Date of Enter into This Industry

Table 34. Mergers & Acquisitions, Expansion Plans

Table 35. Global Nuclear Pharmacy Market Size by Type (2020-2025) & (US$ Million)

Table 36. Global Nuclear Pharmacy Revenue Market Share by Type (2020-2025)

Table 37. Global Nuclear Pharmacy Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 38. Global Nuclear Pharmacy Revenue Market Share by Type (2026-2031)

Table 39. Global Nuclear Pharmacy Market Size by Application (2020-2025) & (US$ Million)

Table 40. Global Nuclear Pharmacy Revenue Market Share by Application (2020-2025)

Table 41. Global Nuclear Pharmacy Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 42. Global Nuclear Pharmacy Revenue Market Share by Application (2026-2031)

Table 43. North America Nuclear Pharmacy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. North America Nuclear Pharmacy Market Size by Country (2020-2025) & (US$ Million)

Table 45. North America Nuclear Pharmacy Market Size by Country (2026-2031) & (US$ Million)

Table 46. Europe Nuclear Pharmacy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Europe Nuclear Pharmacy Market Size by Country (2020-2025) & (US$ Million)

Table 48. Europe Nuclear Pharmacy Market Size by Country (2026-2031) & (US$ Million)

Table 49. Asia-Pacific Nuclear Pharmacy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 50. Asia-Pacific Nuclear Pharmacy Market Size by Region (2020-2025) & (US$ Million)

Table 51. Asia-Pacific Nuclear Pharmacy Market Size by Region (2026-2031) & (US$ Million)

Table 52. Latin America Nuclear Pharmacy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 53. Latin America Nuclear Pharmacy Market Size by Country (2020-2025) & (US$ Million)

Table 54. Latin America Nuclear Pharmacy Market Size by Country (2026-2031) & (US$ Million)

Table 55. Middle East & Africa Nuclear Pharmacy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 56. Middle East & Africa Nuclear Pharmacy Market Size by Country (2020-2025) & (US$ Million)

Table 57. Middle East & Africa Nuclear Pharmacy Market Size by Country (2026-2031) & (US$ Million)

Table 58. Bayer Company Details

Table 59. Bayer Business Overview

Table 60. Bayer Nuclear Pharmacy Product

Table 61. Bayer Revenue in Nuclear Pharmacy Business (2020-2025) & (US$ Million)

Table 62. Bayer Recent Development

Table 63. Curium Pharma Company Details

Table 64. Curium Pharma Business Overview

Table 65. Curium Pharma Nuclear Pharmacy Product

Table 66. Curium Pharma Revenue in Nuclear Pharmacy Business (2020-2025) & (US$ Million)

Table 67. Curium Pharma Recent Development

Table 68. Jubilant Pharmova Company Details

Table 69. Jubilant Pharmova Business Overview

Table 70. Jubilant Pharmova Nuclear Pharmacy Product

Table 71. Jubilant Pharmova Revenue in Nuclear Pharmacy Business (2020-2025) & (US$ Million)

Table 72. Jubilant Pharmova Recent Development

Table 73. GE Healthcare Company Details

Table 74. GE Healthcare Business Overview

Table 75. GE Healthcare Nuclear Pharmacy Product

Table 76. GE Healthcare Revenue in Nuclear Pharmacy Business (2020-2025) & (US$ Million)

Table 77. GE Healthcare Recent Development

Table 78. Cardinal Health Company Details

Table 79. Cardinal Health Business Overview

Table 80. Cardinal Health Nuclear Pharmacy Product

Table 81. Cardinal Health Revenue in Nuclear Pharmacy Business (2020-2025) & (US$ Million)

Table 82. Cardinal Health Recent Development

Table 83. Eli Lilly Company Details

Table 84. Eli Lilly Business Overview

Table 85. Eli Lilly Nuclear Pharmacy Product

Table 86. Eli Lilly Revenue in Nuclear Pharmacy Business (2020-2025) & (US$ Million)

Table 87. Eli Lilly Recent Development

Table 88. Bracco Imaging Company Details

Table 89. Bracco Imaging Business Overview

Table 90. Bracco Imaging Nuclear Pharmacy Product

Table 91. Bracco Imaging Revenue in Nuclear Pharmacy Business (2020-2025) & (US$ Million)

Table 92. Bracco Imaging Recent Development

Table 93. China Isotope & Radiation Company Details

Table 94. China Isotope & Radiation Business Overview

Table 95. China Isotope & Radiation Nuclear Pharmacy Product

Table 96. China Isotope & Radiation Revenue in Nuclear Pharmacy Business (2020-2025) & (US$ Million)

Table 97. China Isotope & Radiation Recent Development

Table 98. Novartis Company Details

Table 99. Novartis Business Overview

Table 100. Novartis Nuclear Pharmacy Product

Table 101. Novartis Revenue in Nuclear Pharmacy Business (2020-2025) & (US$ Million)

Table 102. Novartis Recent Development

Table 103. Siemens Company Details

Table 104. Siemens Business Overview

Table 105. Siemens Nuclear Pharmacy Product

Table 106. Siemens Revenue in Nuclear Pharmacy Business (2020-2025) & (US$ Million)

Table 107. Siemens Recent Development

Table 108. Lantheus Medical Imaging Company Details

Table 109. Lantheus Medical Imaging Business Overview

Table 110. Lantheus Medical Imaging Nuclear Pharmacy Product

Table 111. Lantheus Medical Imaging Revenue in Nuclear Pharmacy Business (2020-2025) & (US$ Million)

Table 112. Lantheus Medical Imaging Recent Development

Table 113. Aurobindo Pharma Company Details

Table 114. Aurobindo Pharma Business Overview

Table 115. Aurobindo Pharma Nuclear Pharmacy Product

Table 116. Aurobindo Pharma Revenue in Nuclear Pharmacy Business (2020-2025) & (US$ Million)

Table 117. Aurobindo Pharma Recent Development

Table 118. ANSTO Company Details

Table 119. ANSTO Business Overview

Table 120. ANSTO Nuclear Pharmacy Product

Table 121. ANSTO Revenue in Nuclear Pharmacy Business (2020-2025) & (US$ Million)

Table 122. ANSTO Recent Development

Table 123. Polatom Company Details

Table 124. Polatom Business Overview

Table 125. Polatom Nuclear Pharmacy Product

Table 126. Polatom Revenue in Nuclear Pharmacy Business (2020-2025) & (US$ Million)

Table 127. Polatom Recent Development

Table 128. NTP Radioisotopes Company Details

Table 129. NTP Radioisotopes Business Overview

Table 130. NTP Radioisotopes Nuclear Pharmacy Product

Table 131. NTP Radioisotopes Revenue in Nuclear Pharmacy Business (2020-2025) & (US$ Million)

Table 132. NTP Radioisotopes Recent Development

Table 133. Yantai Dongcheng Pharmaceutical Company Details

Table 134. Yantai Dongcheng Pharmaceutical Business Overview

Table 135. Yantai Dongcheng Pharmaceutical Nuclear Pharmacy Product

Table 136. Yantai Dongcheng Pharmaceutical Revenue in Nuclear Pharmacy Business (2020-2025) & (US$ Million)

Table 137. Yantai Dongcheng Pharmaceutical Recent Development

Table 138. Saide Biotechnology Company Details

Table 139. Saide Biotechnology Business Overview

Table 140. Saide Biotechnology Nuclear Pharmacy Product

Table 141. Saide Biotechnology Revenue in Nuclear Pharmacy Business (2020-2025) & (US$ Million)

Table 142. Saide Biotechnology Recent Development

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

Table 146. Authors List of This Report

List of Figures

Figure 1. Nuclear Pharmacy Picture

Figure 2. Global Nuclear Pharmacy Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Nuclear Pharmacy Market Share by Type: 2024 VS 2031

Figure 4. Diagnostic Products Features

Figure 5. Therapeutic Products Features

Figure 6. Global Nuclear Pharmacy Market Size Comparison by Isotope Types (2020-2031) & (US$ Million)

Figure 7. Technetium-99m Features

Figure 8. Fluorine-18 Features

Figure 9. Gallium-68 Features

Figure 10. Iodine-123 Features

Figure 11. Indium-111 Features

Figure 12. Copper-64 Features

Figure 13. Xenon-133 Features

Figure 14. Iodine-131 Features

Figure 15. Yttrium-90 Features

Figure 16. Global Nuclear Pharmacy Market Size Comparison by Production Method (2020-2031) & (US$ Million)

Figure 17. Reactor-based Nuclide Production Features

Figure 18. Accelerator-based Nuclide Production Features

Figure 19. Others Features

Figure 20. Global Nuclear Pharmacy Market Size by Application (2020-2031) & (US$ Million)

Figure 21. Global Nuclear Pharmacy Market Share by Application: 2024 VS 2031

Figure 22. Pharmaceutical Case Studies

Figure 23. Hospital Case Studies

Figure 24. Laboratory Case Studies

Figure 25. Nuclear Pharmacy Report Years Considered

Figure 26. Global Nuclear Pharmacy Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 27. Global Nuclear Pharmacy Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 28. Global Nuclear Pharmacy Market Share by Region: 2024 VS 2031

Figure 29. Global Nuclear Pharmacy Market Share by Players in 2024

Figure 30. Global Nuclear Pharmacy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 31. The Top 10 and 5 Players Market Share by Nuclear Pharmacy Revenue in 2024

Figure 32. North America Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. North America Nuclear Pharmacy Market Share by Country (2020-2031)

Figure 34. United States Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Canada Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Europe Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Europe Nuclear Pharmacy Market Share by Country (2020-2031)

Figure 38. Germany Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. France Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. U.K. Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Italy Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Russia Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Ireland Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Asia-Pacific Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Asia-Pacific Nuclear Pharmacy Market Share by Region (2020-2031)

Figure 46. China Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Japan Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. South Korea Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Southeast Asia Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. India Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Australia & New Zealand Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Latin America Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. Latin America Nuclear Pharmacy Market Share by Country (2020-2031)

Figure 54. Mexico Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 55. Brazil Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 56. Middle East & Africa Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 57. Middle East & Africa Nuclear Pharmacy Market Share by Country (2020-2031)

Figure 58. Israel Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 59. Saudi Arabia Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 60. UAE Nuclear Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 61. Bayer Revenue Growth Rate in Nuclear Pharmacy Business (2020-2025)

Figure 62. Curium Pharma Revenue Growth Rate in Nuclear Pharmacy Business (2020-2025)

Figure 63. Jubilant Pharmova Revenue Growth Rate in Nuclear Pharmacy Business (2020-2025)

Figure 64. GE Healthcare Revenue Growth Rate in Nuclear Pharmacy Business (2020-2025)

Figure 65. Cardinal Health Revenue Growth Rate in Nuclear Pharmacy Business (2020-2025)

Figure 66. Eli Lilly Revenue Growth Rate in Nuclear Pharmacy Business (2020-2025)

Figure 67. Bracco Imaging Revenue Growth Rate in Nuclear Pharmacy Business (2020-2025)

Figure 68. China Isotope & Radiation Revenue Growth Rate in Nuclear Pharmacy Business (2020-2025)

Figure 69. Novartis Revenue Growth Rate in Nuclear Pharmacy Business (2020-2025)

Figure 70. Siemens Revenue Growth Rate in Nuclear Pharmacy Business (2020-2025)

Figure 71. Lantheus Medical Imaging Revenue Growth Rate in Nuclear Pharmacy Business (2020-2025)

Figure 72. Aurobindo Pharma Revenue Growth Rate in Nuclear Pharmacy Business (2020-2025)

Figure 73. ANSTO Revenue Growth Rate in Nuclear Pharmacy Business (2020-2025)

Figure 74. Polatom Revenue Growth Rate in Nuclear Pharmacy Business (2020-2025)

Figure 75. NTP Radioisotopes Revenue Growth Rate in Nuclear Pharmacy Business (2020-2025)

Figure 76. Yantai Dongcheng Pharmaceutical Revenue Growth Rate in Nuclear Pharmacy Business (2020-2025)

Figure 77. Saide Biotechnology Revenue Growth Rate in Nuclear Pharmacy Business (2020-2025)

Figure 78. Bottom-up and Top-down Approaches for This Report

Figure 79. Data Triangulation

Figure 80. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Weekly Pill Organizer Market Research Report 2025

Global Pill Organizer with Timer Reminder Market Research Report 2025

Global Diagnostic Guidewire Market Research Report 2024

Pharmaceutical Retail Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Chemical Dosing Units Market Research Report 2025

Influenza Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pharma Contract Service Market Research Report 2025

Global Still s Disease Treatment Market Research Report 2025

Pharmacy Dispensing System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Radiation Therapy Treatment Planning System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Radiopharmaceutical Oral Route Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Radiopharmaceutical Solutions Market Research Report 2025

Radiological Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Anti Radiation Drug Market Research Report 2024

Pharmacy Franchise Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Prescription Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pharmerging Market Research Report 2025

Global Pharmaceutical Validation Services Market Research Report 2025

Global Treatment Planning Software Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions